Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.
Cojutti PG, Gatti M, Punt N, Douša J, Zamparini E, Tedeschi S, Viale P, Pea F. Cojutti PG, et al. Among authors: viale p. Int J Antimicrob Agents. 2024 Jan;63(1):107038. doi: 10.1016/j.ijantimicag.2023.107038. Epub 2023 Nov 21. Int J Antimicrob Agents. 2024. PMID: 37981075
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia.
Gatti M, Pascale R, Cojutti PG, Rinaldi M, Ambretti S, Conti M, Tedeschi S, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: viale p. Int J Antimicrob Agents. 2023 Jan;61(1):106699. doi: 10.1016/j.ijantimicag.2022.106699. Epub 2022 Dec 2. Int J Antimicrob Agents. 2023. PMID: 36464151
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.
Papavramidis T, Gentile I, Cattelan AM, Magnasco L, Viale P, Francisci D, Kofteridis DP, Tiseo G, Giamarellos-Bourboulis EJ, Lagi F, Pinna SM, D'Amico F, La Ferla L, Panagopoulos P, Gattuso G, Sipsas NV, Ruggieri A, Cattaneo A, Corio L, Comandini A, Mascagni P, Bassetti M. Papavramidis T, et al. Among authors: viale p. Int J Antimicrob Agents. 2023 Apr;61(4):106746. doi: 10.1016/j.ijantimicag.2023.106746. Epub 2023 Feb 8. Int J Antimicrob Agents. 2023. PMID: 36758778 Free article.
776 results